The combined 10mg vial reconstitutes readily in bacteriostatic water. A common laboratory approach is reconstitution in 2ml to yield a 5mg/ml total working stock (corresponding to 2.5mg/ml CJC-1295 + 2.5mg/ml ipamorelin), or in 5ml for a 2mg/ml total stock (1mg/ml of each component). The bacteriostatic water should be drawn into a sterile syringe and injected slowly down the inside wall of the lyophilised vial, with the peptide cake allowed to dissolve passively rather than through agitation. Reconstituted blend should be aliquoted, refrigerated at 28C and protected from light, with research stocks typically used within 30 days. For dilution maths across alternative volumes, see our reconstitution calculator guide. For long-term storage protocols, see our peptide storage guide
The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release
Tran et al., 2015
National Collaborating Centre for Womens and Childrens Health (UK)
Significant body composition changes become apparent around week eight to twelve, with peak results occurring between weeks sixteen and twenty-four depending on your protocol and dose
Just like the emphasis of surgical treatment should not be about measuring weight loss but rather maximising health gain, the same must be also true of medical and pharmacological treatment of obesity.
